Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,258
Total Claims
$258K
Drug Cost
51
Beneficiaries
$5,060
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-61%
Opioid rate vs peers
0.9% vs 2.2% avg
+259%
Cost per patient vs peers
$5,060 vs $1,411 avg
+69%
Brand preference vs peers
18.0% vs 10.6% avg
Opioid Prescribing
0.9%
Opioid Rate
11
Opioid Claims
$24
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 216 claims · $179K
Generic: 985 claims · $70K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Diclofenac Sodium | 27 | $32K |
| Semaglutide | 15 | $25K |
| Sitagliptin Phos/Metformin Hcl | 17 | $15K |
| Dulaglutide | 12 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $8,191 |
| Mirabegron | 14 | $7,973 |
| Linaclotide | 13 | $7,297 |
| Insulin Glargine,hum.Rec.Anlog | 14 | $5,288 |
| Memantine Hcl | 30 | $3,942 |
| Losartan Potassium | 82 | $1,183 |
| Atorvastatin Calcium | 92 | $1,051 |
| Duloxetine Hcl | 18 | $679 |
| Omeprazole | 36 | $539 |
| Citalopram Hydrobromide | 27 | $492 |
| Glimepiride | 25 | $472 |
Prescribing Profile
Patient Profile
74
Avg Age
61%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data